 |
 |
 |
 |
 |
 |
Important Notice: The ADDF/ISOA and Alzheimer Research Forum do not endorse any company or product, and listing in this directory is not linked to corporate sponsorship. We do not make a claim to being comprehensive or up to date. If you would like to recommend a company to be listed in the database, please contact us.
|
 |
 |
 |
 |
|
 |
 |
Amylgen SAS Website: Company Website
Company/Resource Category: Models, Services, In vivo, Development, Screening, Consulting, Pharmacology
Profile: Amylgen is a new privately owned contract research organization (CRO) proposing validated in vivo models of neuropathological diseases. Amylgen has models for Alzheimer's, Parkinson's, Excitotoxicity, Depression and Schizophrenia. The company proposes, on each model, a comprehensive panel of morphological, biochemical and behavioral analyses.
|
 |
|
|
 |